# Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study

> **NCT02627053** · PHASE3 · UNKNOWN · sponsor: **Università degli Studi dell'Insubria** · enrollment: 100 (estimated)

## Conditions studied

- Portal Vein Thrombosis
- Mesenteric Vein Thrombosis
- Splenic Vein Thrombosis

## Interventions

- **DRUG:** rivaroxaban

## Key facts

- **NCT ID:** NCT02627053
- **Lead sponsor:** Università degli Studi dell'Insubria
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2019-06
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627053, "Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02627053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*